Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Merck persists in the search for BPH therapeutics

Oct. 18, 1996

Renal-urologic drugs in development at Yamanouchi

Oct. 11, 1996

Three renal-urologic drugs reported in the Fujisawa product pipeline

Oct. 11, 1996

New BPH therapy cleared by the FDA

Oct. 11, 1996

Further launches scheduled for tamsulosin

Oct. 11, 1996

Grant to fund phase III trial of Synsorb Pk

Oct. 4, 1996

FDA approves IVAX drug for IC

Oct. 4, 1996

Glaxo Wellcome reports new diuretics

Oct. 4, 1996

Yamanouchi reports agent for urinary incontinence

Sep. 27, 1996

NC-1800 advances through clinical trials

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...